Word

K

Status

Dead

Status Code

709

Status Date

Friday, December 1, 2023

Serial Number

79185467

Registration Number

5202159

Registration Date

Tuesday, May 16, 2017

Mark Type

3000

Filing Date

Thursday, December 10, 2015

Published for Opposition

Tuesday, February 28, 2017

Cancellation Date

Friday, December 1, 2023

Trademark Owner History

Kyowa Hakko Kirin Co., Ltd. - Original Registrant

Classifications

40 Custom manufacture of pharmaceuticals; extraction, production and synthesis of pharmaceuticals for others; custom manufacture of industrial chemicals; custom manufacture of medical apparatus and medical instruments; manufacture of antibody-producing cells for others

5 Pharmaceuticals, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceuticals for the treatment of cancer and malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; pharmaceutical preparations, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceutical preparations for the treatment of cancer and malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes for use in augmentation, differentiation and cultivation of bone, tissue and cells; cell culture mediums for medical and veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells; cell culture mediums for research and for scientific purposes and for medical or veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; lacteal flour for babies; dietary supplements; dietetic beverages, namely, juice drinks, jelly drinks and milk adapted for medical purposes; dietetic foods, namely, crackers, candy, jelly adapted for medical purposes; beverages for babies adapted for medical purposes; food for babies; dietary supplements for animals

1 Industrial chemicals; chemicals for use in the manufacture of dietary supplements and foods; chemical additives for use in the manufacture of dietary supplements and foods; amino acids for use in the manufacture of dietary supplements and foods; bacteriological culture mediums other than for medical or veterinary purposes; cell culture mediums other than for medical or veterinary purposes; cell culture mediums for research and for scientific purposes, other than for medical or veterinary purposes; plant growth regulating preparations; artificial sweeteners

10 Apparatus for use in medical analysis, namely, apparatus for analysis of biological materials for medical purposes, apparatus for analysis of chemicals for medical purposes, apparatus for analysis of drugs, apparatus for analysis of drug metabolites, medical diagnostic instruments for the analysis of body fluids; medical apparatus, namely, injection device for pharmaceuticals, injection needles for medical purposes, inhalation device for pharmaceuticals, defibrillators, medical apparatus for treating respiratory conditions, infusion devise for administering drugs, infusion pumps for delivering measured amounts of solutions into the bloodstream over time, blood transfusion apparatus, blood component separation apparatus for medical purposes, diagnostic apparatus for detecting cancer, diagnostic apparatus for detecting infection, diagnostic apparatus for detecting the disease state of human illnesses, containers and trays specially designed for transporting and holding pharmaceuticals, high frequency electromagnetic therapy apparatus, low frequency electric therapy apparatus, short wave therapy machines and apparatus, static electric therapy apparatus, ultraviolet radiator units for therapeutic purposes, infrared radiator units for therapeutic purposes, mercury arc lamp units for therapeutic purposes, carbon arc lamp units for therapeutic purposes, massage apparatus for medical purposes; medical instruments, namely, for use in injection for administering drugs, infusion for administering drugs, inhalation for administering drugs, transfusion, separation of blood component for medical purposes, diagnosis for detecting cancer, diagnosis for detecting infection, diagnosis for detecting the disease state of human illnesses, transporting and holding pharmaceuticals, analysis of biological materials for medical purposes, analysis of chemicals for medical purposes, analysis of drugs, analysis of drug metabolites, analysis of body fluids; surgical apparatus, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; surgical instruments, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; gloves for medical purposes

42 Pharmaceutical research; research of chemicals; analysis of chemicals; testing, inspection or research of pharmaceuticals; testing, inspection or research of chemicals; testing, inspection or research of cosmetics; testing, inspection or research of foodstuff; providing technical advice relating to chemical research; providing technical advice relating to pharmaceutical development; providing technical advice relating to chemical development; rental of laboratory apparatus; rental of laboratory instruments

The mark consists of the capital letter "K" in bold is in the color white and is placed against three overlapping ovals in gradations of orange; the area where the three ovals intersect is in the color dark orange, the area where the two ovals intersect is in the color orange, and the area where the three ovals do not intersect is in the color light orange
KYOWA
The color(s) white, dark orange, orange and light orange is/are claimed as a feature of the mark.

Trademark Events

Dec 1, 2023

Cancelled Section 71

May 16, 2022

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 20, 2017

Final Decision Transaction Processed By Ib

Aug 22, 2017

Final Disposition Notice Sent To Ib

Aug 22, 2017

Final Disposition Processed

Aug 16, 2017

Final Disposition Notice Created, To Be Sent To Ib

May 16, 2017

Registered-Principal Register

Feb 28, 2017

Official Gazette Publication Confirmation E-Mailed

Feb 28, 2017

Published For Opposition

Feb 24, 2017

Notification Processed By Ib

Feb 8, 2017

Notification Of Possible Opposition Sent To Ib

Feb 8, 2017

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Feb 8, 2017

Notification Of Notice Of Publication E-Mailed

Jan 26, 2017

Law Office Publication Review Completed

Jan 7, 2017

Approved For Pub - Principal Register

Dec 19, 2016

Teas/Email Correspondence Entered

Dec 18, 2016

Correspondence Received In Law Office

Dec 18, 2016

Teas Request For Reconsideration Received

Oct 27, 2016

Notification For Req For Recon Denied No Appeal Filed

Oct 27, 2016

Action For Req For Recon Denied No Appeal Filed E-Mailed

Oct 27, 2016

Action Req For Recon Denied No Appeal Filed Counted Not Mailed

Oct 5, 2016

Teas/Email Correspondence Entered

Oct 5, 2016

Correspondence Received In Law Office

Oct 5, 2016

Teas Request For Reconsideration Received

Sep 3, 2016

Notification Of Final Refusal Emailed

Sep 3, 2016

Final Refusal E-Mailed

Sep 3, 2016

Final Refusal Written

Aug 12, 2016

Teas/Email Correspondence Entered

Aug 12, 2016

Correspondence Received In Law Office

Aug 12, 2016

Assigned To Lie

Aug 3, 2016

Teas Response To Office Action Received

Aug 3, 2016

Teas Change Of Correspondence Received

May 14, 2016

Refusal Processed By Ib

Apr 11, 2016

Non-Final Action Mailed - Refusal Sent To Ib

Apr 11, 2016

Refusal Processed By Mpu

Apr 8, 2016

Non-Final Action (Ib Refusal) Prepared For Review

Apr 7, 2016

Non-Final Action Written

Apr 5, 2016

Application Filing Receipt Mailed

Apr 1, 2016

Assigned To Examiner

Apr 1, 2016

New Application Office Supplied Data Entered

Mar 31, 2016

Sn Assigned For Sect 66a Appl From Ib